Trading Options with an Edge
Select Page

OCGN

Search by
TICKER SYMBOL

Ocugen Inc

Sector: Manufacturing
Industry: Sanitary Paper Product Manufacturing

7.595

-0.335

(-4.224%)

Volume:

4,106,980

52 week range:

0.2501 - 18.77

Market Cap:

1.51B

Company Description:

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Its breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug - "one to many" and its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. The Company is co-developing Bharat Biotech's COVAXIN™ vaccine candidate for COVID-19 in the U.S. market.